bioAffinity Technologies (BIAF) Debt to Equity: 2022-2025
Historic Debt to Equity for bioAffinity Technologies (BIAF) over the last 2 years, with Sep 2025 value amounting to $0.00.
- bioAffinity Technologies' Debt to Equity fell 29.40% to $0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.00, marking a year-over-year decrease of 29.40%. This contributed to the annual value of $0.01 for FY2024, which is N/A change from last year.
- Latest data reveals that bioAffinity Technologies reported Debt to Equity of $0.00 as of Q3 2025, which was up 122.80% from -$0.02 recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Debt to Equity registered a high of $0.04 during Q3 2022, and its lowest value of -$0.02 during Q2 2025.
- Its 3-year average for Debt to Equity is $0.01, with a median of $0.01 in 2024.
- Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' Debt to Equity was 663.46% (2025), while the steepest drop was 424.40% (2025).
- bioAffinity Technologies' Debt to Equity (Quarterly) stood at $0.02 in 2022, then reached $0.01 in 2023, then grew by 26.85% to $0.01 in 2024, then declined by 29.40% to $0.00 in 2025.
- Its Debt to Equity stands at $0.00 for Q3 2025, versus -$0.02 for Q2 2025 and $0.03 for Q1 2025.